1. Home
  2. PAYC vs VTRS Comparison

PAYC vs VTRS Comparison

Compare PAYC & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAYC
  • VTRS
  • Stock Information
  • Founded
  • PAYC 1998
  • VTRS 1961
  • Country
  • PAYC United States
  • VTRS United States
  • Employees
  • PAYC N/A
  • VTRS N/A
  • Industry
  • PAYC Computer Software: Prepackaged Software
  • VTRS Medicinal Chemicals and Botanical Products
  • Sector
  • PAYC Technology
  • VTRS Health Care
  • Exchange
  • PAYC Nasdaq
  • VTRS Nasdaq
  • Market Cap
  • PAYC 12.2B
  • VTRS 12.2B
  • IPO Year
  • PAYC 2014
  • VTRS N/A
  • Fundamental
  • Price
  • PAYC $161.63
  • VTRS $10.18
  • Analyst Decision
  • PAYC Buy
  • VTRS Hold
  • Analyst Count
  • PAYC 13
  • VTRS 6
  • Target Price
  • PAYC $244.83
  • VTRS $11.17
  • AVG Volume (30 Days)
  • PAYC 584.7K
  • VTRS 8.1M
  • Earning Date
  • PAYC 11-05-2025
  • VTRS 11-06-2025
  • Dividend Yield
  • PAYC 0.82%
  • VTRS 4.46%
  • EPS Growth
  • PAYC N/A
  • VTRS N/A
  • EPS
  • PAYC 8.05
  • VTRS N/A
  • Revenue
  • PAYC $2,001,300,000.00
  • VTRS $14,115,700,000.00
  • Revenue This Year
  • PAYC $10.98
  • VTRS N/A
  • Revenue Next Year
  • PAYC $9.14
  • VTRS $1.61
  • P/E Ratio
  • PAYC $22.83
  • VTRS N/A
  • Revenue Growth
  • PAYC 9.72
  • VTRS N/A
  • 52 Week Low
  • PAYC $180.52
  • VTRS $6.85
  • 52 Week High
  • PAYC $267.76
  • VTRS $13.55
  • Technical
  • Relative Strength Index (RSI)
  • PAYC 17.38
  • VTRS 47.99
  • Support Level
  • PAYC $197.19
  • VTRS $10.24
  • Resistance Level
  • PAYC $186.28
  • VTRS $10.47
  • Average True Range (ATR)
  • PAYC 5.90
  • VTRS 0.27
  • MACD
  • PAYC -2.40
  • VTRS 0.01
  • Stochastic Oscillator
  • PAYC 10.13
  • VTRS 15.76

About PAYC Paycom Software Inc.

Founded in 1998, Paycom is a human capital management software-as-a-service provider addressing customer requirements surrounding payroll, talent acquisition, talent management, HR management, as well as time and labor. The company primarily services midsize businesses within the United States, targeting businesses with 50-10,000 employees. The company primarily generates revenue through the sale of subscriptions providing access to its HCM platform. To a lesser extent, the company also generates revenue from implementation services provided to customers as well as interest income generated from customer funds. As of fiscal 2024, the company serviced slightly over 37,500 customers and stored data on over 7 million employees.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: